March 8, 2022
Gifu University
Keio University
A research group, including Assistant Professor Yuji Kamatari of the Glycan & Life Systems Core Research Center at Gifu University, Shintaro Kimura, a fourth-year student at the United Graduate School of Veterinary Sciences, Associate Professor Hiroaki Koshina, Professor Yoko Morita and Professor Takafumi Furuta of the Faculty of Engineering, and Professor Yoshiaki Furukawa of the Faculty of Science and Technology at Keio University, has reported that the GIF compound, an oxindole compound originating from Gifu University, suppresses the aggregation of multiple proteins that cause neurodegenerative diseases. As a new compound effective in suppressing the aggregation of multiple proteins, it is expected to be applied to the treatment of neurodegenerative diseases in humans and animals.
These research results were published in the online edition of the journalBiochimica et Biophysica Acta (BBA) - General Subjectson Tuesday, February 22, 2022.
For the full press release, please see below.